Increasing access to integrated ESKD care as part of universal health coverage

David C H Harris¹, Simon J Davies², Fredric O Finkelstein³, Vivekanand Jha⁴, Jo-Ann Donner⁵, Georgi Abraham⁶, Aminu K Bello⁷, Fergus J Caskey⁸, Guillermo Garcia Garcia⁹, Paul Harden¹⁰, Brenda Hemmelgarn¹¹, David W Johnson¹², Nathan W Levin¹³, Valerie A Luyckx¹⁴, Dominique E Martin¹⁵, Mignon I McCulloch¹⁶, Mohammed Rafique Moosa¹⁷, Philip J O'Connell¹⁸, Ikechi G Okpechi¹⁹, Roberto Pecoits Filho²⁰, Kamal D Shah²¹, Laura Sola²², Charles Swanepoel²³, Marcello Tonelli²⁴, Ahmed Twahir²⁵, Wim van Biesen²⁶, Cherian Varghese²⁷, Chih-Wei Yang²⁸, Carlos Zuniga²⁹; Working Groups of the International Society of Nephrology’s 2nd Global Kidney Health Summit

Collaborators, Affiliations

Collaborators

Working Groups of the International Society of Nephrology’s 2nd Global Kidney Health Summit:
Ali K Abu Alfa, Harith M Aljubori, Mona N Alrukhaimi, Sharon P Andreoli, Gloria Ashuntantang, Ezequiel Bellorin-Font, Bassam Bernieh, Fuad M Ibhais, Peter G Blake, Mark Brown, Edwina Brown, Sakarn Bunnag, Tak Mao Chan, Yuqing Chen, Rolando Claure-Del Granado, Stefaan Claus, Allan Collins, Cecile Couchoud, Alfonso Cueto-Manzano, Brett Cullis, Walter Douthat, Gavin Dreyer, Somchai Eiam-Ong, Felicia U Eke, John Feehally, Mohammad A Ghnaimat, BakLeong Goh, Mohamed H Hassan, Fan Fan Hou, Kitty Jager, Kamyar Kalantar-Zadeh, Rumeyza T Kazancioglu, Adeera Levin, Adrian Liew, Marla McKnight, Yewondwassesn Tadesse Mengistu, Rachael L Morton, Elmi Muller, Fliss E M Murtagh, Saraladevi Naicker, Masaomi Nangaku, Abdou Niang, Gregorio T Obrador, Shahrzad Ossareh, Jeffrey Perl, Muhibur Rahman, Harun Ur Rashid, Marie Richards, Eric Rondeau, Manisha Sahay, Abdulkarim Saleh, Daniel Schneditz, Irma Tchokhonelidze, Vladimir Tesar, Michele Trask, Kriang Tungsanga, Tushar Vachharajani, Rachael C Walker, Robert Walker, Anthony J O Were, Qiang Yao, Karen Yeates, Xueqing Yu, Elena Zakharova, Alexander Zemchenkov, Ming-Hui Zhao

Affiliations

¹ Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. Electronic address: david.harris@sydney.edu.au.
² Faculty of Medicine and Health Sciences, Keele University, Keele, UK.
³ Department of Medicine, Yale University, New Haven, Connecticut, USA.
⁴ George Institute for Global Health India, New Delhi, India; University of Oxford, Oxford, UK.
⁵ International Society of Nephrology, Brussels, Belgium.
⁶ Nephrology Division, Madras Medical Mission Hospital, Pondicherry Institute of Medical Sciences, Chennai, India.
⁷ Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
⁸ UK Renal Registry, Learning and Research, Southmead Hospital, Bristol, UK; Population Health Sciences, University of Bristol, Bristol, UK; The Richard Bright Renal Unit, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
⁹ Servicio de Nefrologia, Hospital Civil de Guadalajara Fray Antonio Alcalde, University of Guadalajara Health Sciences Center, Hospital 278, Guadalajara, JAL, Mexico.
¹⁰ Oxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
¹¹ Departments of Community Health Sciences and Medicine, University of Calgary, Calgary, Alberta, Canada.
¹² Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia; Metro South and Ipswich Nephrology and Transplant Services (MINTS), Princess Alexandra Hospital, Brisbane, Australia.
¹³ Mount Sinai Icahn School of Medicine, New York, New York, USA.
¹⁴ Institute of Biomedical Ethics, University of Zurich, Zurich, Switzerland; Lecturer, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
¹⁵ School of Medicine, Deakin University, Melbourne, Victoria, Australia.
¹⁶ Paediatric Intensive and Critical Unit, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.
¹⁷ Division of Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, South Africa.
¹⁸ Renal Unit, University of Sydney at Westmead Hospital, Sydney, New South Wales, Australia; Westmead Clinical School, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
¹⁹ Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa; Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa.
²⁰ School of Medicine, Pontificia Universidade Catolica do Paraná, Curitiba, Brazil; Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
²¹ NephroPlus Dialysis Centres, Hyderabad, India.
²² Dialysis Unit, CASMU-IAMPP, Montevideo, Uruguay.
²³ Division of Nephrology and Hypertension, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
²⁴ Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
²⁵ Parklands Kidney Centre, Nairobi, Kenya; Department of Medicine, The Aga Khan University Hospital, Nairobi, Kenya.
²⁶ Nephrology Department, Ghent University Hospital, Ghent, Belgium.
²⁷ World Health Organization, Geneva, Switzerland.
²⁸ Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
²⁹ School of Medicine, Catholic University of Santisima Concepción, Concepcion, Chile.

PMID: 30904051
DOI: 10.1016/j.kint.2018.12.005

Free article

Increasing access to integrated ESKD care as part of universal health coverage

David C H Harris et al. Kidney Int. 2019 Apr.

Free article

. 2019 Apr;95(4S):S1-S33.

doi: 10.1016/j.kint.2018.12.005.

Authors

Collaborators

Working Groups of the International Society of Nephrology’s 2nd Global Kidney Health Summit:
Ali K Abu Alfa, Harith M Aljubori, Mona N Alrukhaimi, Sharon P Andreoli, Gloria Ashuntantang, Ezequiel Bellorin-Font, Bassam Bernieh, Fuad M Ibhais, Peter G Blake, Mark Brown, Edwina Brown, Sakarn Bunnag, Tak Mao Chan, Yuqing Chen, Rolando Claure-Del Granado, Stefaan Claus, Allan Collins, Cecile Couchoud, Alfonso Cueto-Manzano, Brett Cullis, Walter Douthat, Gavin Dreyer, Somchai Eiam-Ong, Felicia U Eke, John Feehally, Mohammad A Ghnaimat, BakLeong Goh, Mohamed H Hassan, Fan Fan Hou, Kitty Jager, Kamyar Kalantar-Zadeh, Rumeyza T Kazancioglu, Adeera Levin, Adrian Liew, Marla McKnight, Yewondwassesn Tadesse Mengistu, Rachael L Morton, Elmi Muller, Fliss E M Murtagh, Saraladevi Naicker, Masaomi Nangaku, Abdou Niang, Gregorio T Obrador, Shahrzad Ossareh, Jeffrey Perl, Muhibur Rahman, Harun Ur Rashid, Marie Richards, Eric Rondeau, Manisha Sahay, Abdulkarim Saleh, Daniel Schneditz, Irma Tchokhonelidze, Vladimir Tesar, Michele Trask, Kriang Tungsanga, Tushar Vachharajani, Rachael C Walker, Robert Walker, Anthony J O Were, Qiang Yao, Karen Yeates, Xueqing Yu, Elena Zakharova, Alexander Zemchenkov, Ming-Hui Zhao

Affiliations

¹ Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. Electronic address: david.harris@sydney.edu.au.
² Faculty of Medicine and Health Sciences, Keele University, Keele, UK.
³ Department of Medicine, Yale University, New Haven, Connecticut, USA.
⁴ George Institute for Global Health India, New Delhi, India; University of Oxford, Oxford, UK.
⁵ International Society of Nephrology, Brussels, Belgium.
⁶ Nephrology Division, Madras Medical Mission Hospital, Pondicherry Institute of Medical Sciences, Chennai, India.
⁷ Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
⁸ UK Renal Registry, Learning and Research, Southmead Hospital, Bristol, UK; Population Health Sciences, University of Bristol, Bristol, UK; The Richard Bright Renal Unit, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
⁹ Servicio de Nefrologia, Hospital Civil de Guadalajara Fray Antonio Alcalde, University of Guadalajara Health Sciences Center, Hospital 278, Guadalajara, JAL, Mexico.
¹⁰ Oxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
¹¹ Departments of Community Health Sciences and Medicine, University of Calgary, Calgary, Alberta, Canada.
¹² Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia; Metro South and Ipswich Nephrology and Transplant Services (MINTS), Princess Alexandra Hospital, Brisbane, Australia.
¹³ Mount Sinai Icahn School of Medicine, New York, New York, USA.
¹⁴ Institute of Biomedical Ethics, University of Zurich, Zurich, Switzerland; Lecturer, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
¹⁵ School of Medicine, Deakin University, Melbourne, Victoria, Australia.
¹⁶ Paediatric Intensive and Critical Unit, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa.
¹⁷ Division of Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, South Africa.
¹⁸ Renal Unit, University of Sydney at Westmead Hospital, Sydney, New South Wales, Australia; Westmead Clinical School, The Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
¹⁹ Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa; Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa.
²⁰ School of Medicine, Pontificia Universidade Catolica do Paraná, Curitiba, Brazil; Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
²¹ NephroPlus Dialysis Centres, Hyderabad, India.
²² Dialysis Unit, CASMU-IAMPP, Montevideo, Uruguay.
²³ Division of Nephrology and Hypertension, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
²⁴ Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
²⁵ Parklands Kidney Centre, Nairobi, Kenya; Department of Medicine, The Aga Khan University Hospital, Nairobi, Kenya.
²⁶ Nephrology Department, Ghent University Hospital, Ghent, Belgium.
²⁷ World Health Organization, Geneva, Switzerland.
²⁸ Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
²⁹ School of Medicine, Catholic University of Santisima Concepción, Concepcion, Chile.

PMID: 30904051
DOI: 10.1016/j.kint.2018.12.005

Abstract

The global nephrology community recognizes the need for a cohesive strategy to address the growing problem of end-stage kidney disease (ESKD). In March 2018, the International Society of Nephrology hosted a summit on integrated ESKD care, including 92 individuals from around the globe with diverse expertise and professional backgrounds. The attendees were from 41 countries, including 16 participants from 11 low- and lower-middle-income countries. The purpose was to develop a strategic plan to improve worldwide access to integrated ESKD care, by identifying and prioritizing key activities across 8 themes: (i) estimates of ESKD burden and treatment coverage, (ii) advocacy, (iii) education and training/workforce, (iv) financing/funding models, (v) ethics, (vi) dialysis, (vii) transplantation, and (viii) conservative care. Action plans with prioritized lists of goals, activities, and key deliverables, and an overarching performance framework were developed for each theme. Examples of these key deliverables include improved data availability, integration of core registry measures and analysis to inform development of health care policy; a framework for advocacy; improved and continued stakeholder engagement; improved workforce training; equitable, efficient, and cost-effective funding models; greater understanding and greater application of ethical principles in practice and policy; definition and application of standards for safe and sustainable dialysis treatment and a set of measurable quality parameters; and integration of dialysis, transplantation, and comprehensive conservative care as ESKD treatment options within the context of overall health priorities. Intended users of the action plans include clinicians, patients and their families, scientists, industry partners, government decision makers, and advocacy organizations. Implementation of this integrated and comprehensive plan is intended to improve quality and access to care and thereby reduce serious health-related suffering of adults and children affected by ESKD worldwide.

Keywords: ESKD; advocacy; conservative care; dialysis; end-stage kidney disease; funding; training; transplantation; universal health coverage.

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Increasing access to integrated ESKD care as part of universal health coverage

Collaborators

Affiliations

Increasing access to integrated ESKD care as part of universal health coverage

Authors

Collaborators

Affiliations

Abstract

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical